Hamilton Health Sciences Corporation

11 marketed · 11 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Hamilton Health Sciences Corporation

What are Hamilton Health Sciences Corporation's marketed drugs?

Top marketed products include Active ASA, Active Clonidine, budesonide 400 mcg, CBD+THC, Depo-Medrol, Olanzapine & Quetiapine.

What is Hamilton Health Sciences Corporation's pipeline?

Hamilton Health Sciences Corporation has 11 drugs in Phase 3, 4 in Phase 2, 2 in Phase 1. Late-stage candidates include 0.45%NaCl, After CPB Tranexamic Acid, Before CPB Tranexamic Acid, Chemotherapy/Radiation.

How many employees does Hamilton Health Sciences Corporation have?

Hamilton Health Sciences Corporation has approximately 3,759 employees.

Related